Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy
Open Access
- 16 February 2005
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (7) , 1620-1628
- https://doi.org/10.1523/jneurosci.4279-04.2005
Abstract
Anti-GD1a ganglioside antibodies (Abs) are the serological hallmark of the acute motor axonal form of the post-infectious paralysis, Guillain-Barré syndrome. Development of a disease model in mice has been impeded by the weak immunogenicity of gangliosides and the apparent resistance of GD1a-containing neural membranes to anti-GD1a antibody-mediated injury. Here we used mice with altered ganglioside biosynthesis to generate such a model at motor nerve terminals. First, we bypassed immunological tolerance by immunizing GD1a-deficient, β-1,4-N-acetylgalactosaminyl transferase knock-out mice with GD1a ganglioside-mimicking antigens fromCampylobacter jejuniand generated high-titer anti-GD1a antisera and complement fixing monoclonal Abs (mAbs). Next, we exposedex vivonerve-muscle preparations from GD1a-overexpressing, GD3 synthase knock-out mice to the anti-GD1a mAbs in the presence of a source of complement and investigated morphological and electrophysiological damage. Dense antibody and complement deposits were observed only over presynaptic motor axons, accompanied by severe ultrastructural damage and electrophysiological blockade of motor nerve terminal function. Perisynaptic Schwann cells and postsynaptic membranes were unaffected. In contrast, normal mice were not only unresponsive to immunization with GD1a but also resistant to neural injury during anti-GD1a Ab exposure, demonstrating the central role of membrane antigen density in modulating both immune tolerance to GD1a and axonal susceptibility to anti-GD1a Abmediated injury. Identical paralyzing effects were observed when testing mouse and human anti-GD1a-positive sera. These data indicate that anti-GD1a Abs arise via molecular mimicry and are likely to be clinically relevant in injuring peripheral nerve axonal membranes containing sufficiently high levels of GD1a.Keywords
This publication has 47 references indexed in Scilit:
- Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathyBrain, 2004
- Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathiesBrain, 2004
- Dysfunction at the motor end‐plate and axon membrane in Guillain–Barré syndrome: A single‐fiber EMG studyMuscle & Nerve, 2003
- Localization of major gangliosides in the PNS: implications for immune neuropathiesBrain, 2002
- Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides inCampylobacter jejuniStrains Associated with Guillain-Barré SyndromeInfection and Immunity, 2002
- b-series Ganglioside Deficiency Exhibits No Definite Changes in the Neurogenesis and the Sensitivity to Fas-mediated Apoptosis but Impairs Regeneration of the Lesioned Hypoglossal NervePublished by Elsevier ,2002
- Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic SeizuresJournal of Biological Chemistry, 2001
- Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparationsJournal of Clinical Investigation, 1999
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Chemical Structures of the Core Region of Campylobacter Jejuni O:3 Lipopolysaccharide and an Associated PolysaccharideEuropean Journal of Biochemistry, 1995